|
⚲
|
| Sequel Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001414879 |
| Sale | 2009-08-03 ($8.4 M Offered, $3.0 M Sold) |
| Fund | |
| Phone | 8585090455 |
| Address | 12750 High Bluff Drive San Diego, 92130 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| David Lowe | |
| Eckard Weber | |
| Nina Kjellson | |
| Mark Murgerditchian | |
| Randall Woods | |
| Howard Dittrich | |
| Stuart Collinson | |
| Daniel Turner III | |
| Joseph Turner | |
| Brian Farmer |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Jackson Square Ventures IV, L.P.
✚
|
0.0 | |
|
Jacobs Gerard M
✚
|
0.0 | |
|
Jacobson Neil
✚
|
0.0 | |
|
Jacobson Nolan
✚
|
0.0 | |
|
Jacobson Perry
✚
|
0.0 | |
|
Jacobus hubert hermogenes
✚
|
0.0 | |
|
Jacqueline Investments, LLC
✚
|
0.0 | |
|
Jaeckin Anne
✚
|
0.0 | |
|
Jaeger Stephen O
✚
|
0.0 | |
|
Jackson Square Associates IV, L.P.
✚
|
0.0 |